• Case Report • Previous Articles
LI Si-xiu, LIU Ping, DENG Jia, CHEN Jia-lei, MAO Dan-dan, HU Wen-guang
李思秀, 刘平, 邓佳, 陈嘉蕾, 毛丹丹, 胡文广
|  Gilissen C, Hehir-Kwa JY, Thung DT, et al. Genome sequencing identifies major causes of severe intellectual disability[J]. Nature, 2014, 511(7509):344-347.
 Deciphering Developmental Disorders Study.Large-scale discovery of novel genetic causes of developmental disorders[J]. Nature, 2015, 519(7542):223-228.
 Houge G, Haesen D, Vissers L, et al. B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability[J]. J Clin Invest, 2015, 125(8):3051-3062.
 Lenaerts L, Reynhout S, Verbinnen I, et al. The broad phenotypic spectrum of PPP2R1A-related neurodevelopmental disorders correlates with the degree of biochemical dysfunction[J]. Genet Med, 2021,23(2):352-362.
 Wallace A, Caruso P, Karaa A. A newborn with severe ventriculomegaly:Expanding the PPP2R1A gene mutation phenotype[J]. J Pediatr Genet, 2019, 8(4):240-243.
 Zhang Y, Li H, Wang H, et al. A De Novo Variant identified in the PPP2R1A gene in an infant induces neurodevelopmental abnormalities[J]. Neurosci Bull, 2020, 36(2):179-182.
 Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015,17(5):405-424.
 Janssens V, Goris J. Protein phosphatase 2A: A highly regulated family of serine/threonine phosphatases implicated in cell growth and signaling[J]. Biochem J, 2001, 353(Pt 3):417-439.
 Reynhout S, Janssens V. Physiologic functions of PP2A: Lessons from genetically modified mice[J].Biochim Biophys Acta Mol Cell Res, 2019, 1866(1):31-50.
 Sents W, Ivanova E, Lambrecht C, et al. The biogenesis of active protein phosphatase 2A holoenzymes: A tightly regulated process creating phosphatase specificity[J]. Febs J,2013,280(2):644-661.
 McConechy MK, Anglesio MS,Kalloger SE, et al. Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas[J]. J Pathol, 2011, 223(5):567-573.
 Shih IM, Panuganti PK, Kuo KT, et al. Somatic mutations of PPP2R1A in ovarian and uterine carcinomas[J]. Am J Pathol, 2011, 178(4):1442-1447.
 Jeong AL, Han S, Lee S, et al. Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway[J]. Sci Rep, 2016,6:27391.
 Taylor SE, O'Connor CM, Wang Z, et al. The highly recurrent PP2A Aα subunit mutation P179R alters protein structure and impairs PP2A enzyme function to promote endometrial tumorigenesis[J]. Cancer Res, 2019,79(16):4242-4257.
 O'Connor CM, Leonard D, Wiredja D, et al. Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitors[J]. Oncogene. 2020;39(3):703-717.
 Haesen D, Asbagh L A, Derua R,et al.Recurrent PPP2R1A mutations in uterine cancer act through a dominant-negative mechanism to promote malignant cell growth [J]. Cancer Res, 2016, 76(19):5719-5731.
 Verbinnen I, Vaneynde P, Reynhout S, et al. Protein Phosphatase 2A (PP2A) mutations in brain function, development, and neurologic disease [J].Biochem Soc Trans, 2021, 49(4):1567-1588.
 Brinkmann V, Billich A, Baumruker T, et al.Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis [J]. Nat Rev Drug Discov, 2010, 9(11):883-897.
 Clark AR, Ohlmeyer M.Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration [J]. Pharmacol Ther, 2019, 201:181-201.
 Gutierrez A, Pan L, RGroen R W J, et al. Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia[J]. J Clin Invest, 2014, 124(2):644-655.
|||CHEN Yi-ru, CHEN Wen-xiong. Research progress in neurodevelopmental disorder caused by KIF5C gene mutation [J]. Chinese Journal of Child Health Care, 2023, 31(2): 171-175.|
|||SHU Yao, ZHANG Ying-bo. Systematic review on the effect of motor skills intervention on fundamental motor skills of children and adolescents with intellectual disabilities [J]. Chinese Journal of Child Health Care, 2022, 30(7): 770-774.|
|||BU Qing-guo, ZHANG Lei, WANG Dan-dan, WU Xue-ping. Literature analysis of exercise intervention study on overweight and obesity in children andadolescents with intellectual disability from 2010 to 2020 [J]. Chinese Journal of Child Health Care, 2021, 29(9): 986-991.|
|||ZHU Mei-jun, JI Ju-hua, ZHU Jie, SONG Lei, ZHOU Feng, ZHAO Jin-hua. Study on the correlation between DNA load of drug-resistance mycoplasma pneumoniae and 23sRNA mutation at 2063 locus in children [J]. Chinese Journal of Child Health Care, 2021, 29(9): 1017-1020.|
|||CHEN Lu-lu, TONG Guang-lei, ZHOU Tao-cheng, LI Hong, XU Yan-hong, SU Wei, LUO Yuan-yuan, LIANG Dong. Investigation and clinical phenotypic analysis of gene copy number variation in 120 children with intellectual disability/developmental delay in Anhui province [J]. Chinese Journal of Child Health Care, 2021, 29(11): 1172-1175.|
|||ZHANG Ya-guo, YE Piao, OU Ming-cai, YANG Yun-xia, CHEN Xue-lian, YANG Li-juan. Genetic analysis of 43 children with hyperphenylalaninemia in some regions of Sichuan [J]. journal1, 2020, 28(11): 1255-1258.|
|||SUN Ying-mei, SONG Dong-po, WANG Wei-qing, LI Wen-jie. Analysis on the diagnosis,treatment and gene mutation of neonatal primary carnitine deficiency [J]. journal1, 2019, 27(8): 820-823.|
|||TAN Jian-qiang, YAN Ti-zhen, HUANG Jun, TANG Ning, YUAN De-jian, CAI Ren. Analysis on clinical characteristics and gene mutation of children with X-linked severe combined immunodeficiency [J]. journal1, 2019, 27(4): 439-442.|
|||SUN Ying-mei, YU Chun-dong, LYU Jin-feng, LYU Ya-nan, LI Wen-jie. Analysis of gene mutation characteristics of medium chain acyl-CoA dehydrogenase deficiency by neonatal screening [J]. journal1, 2019, 27(10): 1071-1074.|
|||WANG Hong-qin,WEI Ming,LI Wen-jie. Prevalence and genotypes of the glucose-6-phosphate dehydrogenase deficiency in neonates from Qingdao [J]. journal1, 2018, 26(11): 1233-1235.|
WANG Hong, WANG Xiao-yan, WU Mei-rong, ZHAO Zhi-wei, DAI Qiong, LIU Xing-lian, XU Hai-qing.
Study on the specificity of amyloid precursor protein and brain derived neurotrophic factor
in peripheral blood in children with autism spectrum disorder [J]. journal1, 2018, 26(10): 1133-1136.
|||CHEN Xiao-yang, ZHAO Zheng-yan. Vitamin D-dependent rickets [J]. journal1, 2017, 25(5): 478-480.|
|||LI Tian-tian, ZHANG Li-qin. Research progress on gene mutation in X-linked dominate hypophosphatemia rickets [J]. journal1, 2017, 25(12): 1233-1235.|
|||YANG Li,WU De,TANG Jiu-lai.. Clinical characteristics and molecular genetics of three patients with Dravet syndrome. [J]. journal1, 2016, 24(10): 1037-1040.|
|||LIU Lu,LI Hui-chao,CHAI Jian,SHAO Hui-ying,YI Ming-ji,CHEN Pei-jie,LIU Shi-guo,YAN Sheng-li. Study on DUOXA2 gene mutation in patients with congenital hypothyroidism and goiter. [J]. journal1, 2015, 23(1): 7-10.|